Seven Top M&A Deal Killers In this whitepaper, our guest experts reveal how to avoid the seven top M&A deal killers. Best Practices & Trends Finance Mergers & Acquisitions Other Topics Whitepapers
Best Practices for Fundraising and M&A Due Diligence Chinese 并购交易中的意外事件可能会导致交易延迟,甚至完全破坏交易。但如果您知道如何预防这些意外事件,它们是可以避免的。 Due Diligence Fundraising Mergers & Acquisitions Whitepapers
Best Practices for Fundraising and M&A Due Diligence Korean 인수 합병 거래 중 예상하지 못한 일이 벌어진다면 거래의 지연을 야기할 수 있으며 심지어 거래를 완전히 무마시킬 수도 있습니다. 그러나 그러한 상황을 대비하여 불미스러운 일을 피할 수 있습니다. Due Diligence Fundraising Whitepapers
Demystifying M&A Valuation Chinese 估值是每笔交易中最关键的部分,但它往往是最不被理解的部分。与Ascento Capital的管理合伙人本·博伊塞万(Ben Boissevain)一起探讨估值的细微差别、估值框架以及正确估值的流程。 Mergers & Acquisitions Valuation Whitepapers
Essential Steps to Successful Biopharma Partnering This whitepaper provides a strategic perspective coupled with actionable tips to help guide you through the essential steps that will help maximize your chance of achieving success in biopharma partnering. BioPharma Licensing & Partnering Life Sciences Whitepapers
Preparing Your Company for the M&A Process When it’s time to exit your business, being prepared and having a well-planned exit strategy can be the difference between a good transaction and a great one. Best Practices & Trends Finance Mergers & Acquisitions Whitepapers
Best Practices for Fundraising and M&A Due Diligence This whitepaper explores the importance of establishing early goals and objectives for the process, how to get the right people to ask the right questions in advance of the process, how to build credibility by defining goals and demonstrating they can be achieved, and much more. Due Diligence Finance Fundraising Mergers & Acquisitions Whitepapers
Getting Ready for a Biopharma Partnering Deal This whitepaper provides actionable advice for Biotech business development leaders on how to get ready for a partnering deal. Best Practices & Trends BioPharma Licensing & Partnering Life Sciences Series Whitepapers
Demystifying Tech M&A Valuation In this whitepaper, explore the nuances of valuation, its framework and the processes for getting it right. Best Practices & Trends Finance Mergers & Acquisitions Other Topics Valuation Whitepapers
M&A Negotiations This whitepaper shares the most common scenarios that arise when you are selling your company, the choices you have when negotiating the terms of the sale, and which choices are your best ones, as supported by academic research are covered. Best Practices & Trends Life Sciences Mergers & Acquisitions Negotiation Whitepapers
The Nuts & Bolts of Due Diligence in Biopharma Partnering This whitepaper focuses on best practices in due diligence with the goal of forming productive biopharma partnerships. Best Practices & Trends BioPharma Due Diligence Licensing & Partnering Life Sciences Series Whitepapers
How to Win at the Partnering Game In this white paper, Linda Pullan provides a review of the rules of the partnering game – whether it’s partnering from preclinical to late clinical development – to provide an understanding of what to expect in moving from introductions to negotiations of a license or acquisition and how to win with a clear strategy. Best Practices & Trends BioPharma Licensing & Partnering Life Sciences Series Whitepapers